In a phase 3 trial of 196 patients with 5-20 brain metastases, stereotactic radiation vs hippocampal-avoidance whole brain radiation improved symptom severity and interference over 6 months (mean difference -1.06, 95% CI -1.54 to -0.58); only 83 completed 6 months.
RCTn = 196
Aizer et al. Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial